Small-cap stock under ₹50 jumps 7% despite weak trends on Dalal Street; here’s why | Target price, stop-loss
vialivemint.com6d ago

Sudarshan Pharma shares rose 7% on Wednesday after the company migrated from BSE’s SME platform to the NSE main board. Its board is scheduled to review Q2 FY27 results and a potential fundraising proposal on October 29.
Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to livemint.com's own reporting rather than reproducing it — the excerpt above comes from livemint.com's own feed.
Read the full story on livemint.com ↗